Dialysis and MAKE Risk

Cross-source consensus on Dialysis and MAKE Risk from 1 sources and 6 claims.

1 sources · 6 claims

Risks & contraindications

During follow-up, the cohort experienced 221 ESKD events and 146 deaths. — Trajectories of metabolic risk clusters and adverse outcomes in patients with chronic kidney disease: a prospective cohort study in Taiwan
Group I had significantly longer dialysis-free and MAKE-free survival than the other trajectory groups. — Trajectories of metabolic risk clusters and adverse outcomes in patients with chronic kidney disease: a prospective cohort study in Taiwan
Dialysis incidence increased from Group I to Group IV. — Trajectories of metabolic risk clusters and adverse outcomes in patients with chronic kidney disease: a prospective cohort study in Taiwan
In the fully adjusted model, Group IV remained significantly associated with dialysis initiation. — Trajectories of metabolic risk clusters and adverse outcomes in patients with chronic kidney disease: a prospective cohort study in Taiwan
In the fully adjusted model, Group IV had significantly higher MAKE risk. — Trajectories of metabolic risk clusters and adverse outcomes in patients with chronic kidney disease: a prospective cohort study in Taiwan
Some elevated risk estimates for Groups II and III lost statistical significance after fuller biochemical adjustment. — Trajectories of metabolic risk clusters and adverse outcomes in patients with chronic kidney disease: a prospective cohort study in Taiwan